Maplight Targeting Anxiety, Depression in Parkinson’s With $8.1M MJFF Grant
MapLight Therapeutics will use an $8.1 million three-year grant to tackle the common symptoms of anxiety and depression in Parkinson’s disease. The Michael J. Fox Foundation for Parkinson’s Research (MJFF) grant will enable the biopharmaceutical company to open an expansive, systematic exploration of brain circuits and…